Contribution: Industrial Research Assistance Program – Contributions to Firms
Okaki Health Intelligence Inc.
$212,000.00
PRescribing Outcomes Modeled through Intelligent Systems Engineering (PROMISE)
FY 2021-22 · 2021-09-01
Summary
Develop and test a machine learning model to predict the 30-day risk of hospitalization, emergency department visit (ED), or death after a person in Alberta receives an opioid or benzodiazepine prescription and develop/validate an end-to-end platform to simulate the use of this ML model as part of Alberta's prescription monitoring program for controlled drugs (Alberta TPP).
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Calgary|Calgary, Alberta, Canada
Recipient Type
For-profit organization
Business Number
800653354
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
As published
Agreement End Date
2022-08-31
Agreement Number
977782
Agreement Start Date
2021-09-01
Agreement Title
PRescribing Outcomes Modeled through Intelligent Systems Engineering (PROMISE)
Agreement Title (French)
PRescribing Outcomes Modeled through Intelligent Systems Engineering (PROMISE) (décrire les résultats modélisés par l'ingénierie des systèmes intelligents)
Agreement Type
Contribution
Agreement Value
$212,000.00
Amendment Number
0
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Develop and test a machine learning model to predict the 30-day risk of hospitalization, emergency department visit (ED), or death after a person in Alberta receives an opioid or benzodiazepine prescription and develop/validate an end-to-end platform to simulate the use of this ML model as part of Alberta's prescription monitoring program for controlled drugs (Alberta TPP).
Description (French)
Élaborer et tester un modèle d'apprentissage machine pour prédire le risque dans les 30 jours d'une hospitalisation, d'une visite à l'urgence ou d'un décès après qu'une personne en Alberta ait reçu une ordonnance d'opioïdes ou de benzodiazépines, et élaborer/valider une plateforme de bout en bout pour simuler l'utilisation de ce modèle AM dans le cadre du programme de surveillance des ordonnances de médicaments contrôlés de l'Alberta (Alberta TPP).
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Calgary Confederation
Federal Riding (French)
Calgary Confederation
Federal Riding Number
48005
NAICS Code
511211
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
800653354
Recipient City
Calgary|Calgary
Recipient Country
CA
Recipient Legal Name
Okaki Health Intelligence Inc.
Recipient Postal Code
T2L 2K7
Recipient Province or Territory
AB
Recipient Type
F
Reference Number
172-2021-2022-Q2-977782
